We show that CBN profoundly inhibits neuroblastoma cell proliferation, angiogenesis, and invasion in a dose-dependent manner, and induces cell cycle arrest through the inhibition of the AKT pathway and downregulation of miR-34a’s targets CDK2 and E2F1. This evidence concerns the gene AKT1 and neuroblastoma.